moble-icon.png
Setra Blog

September 18, 2019

Upcoming Changes to USP 797

USP 797 revisions were published on June 1, 2019. The clarity and readability of documentation is a concern for all facilities and significantly impacts those who compound both hazardous and non-hazardous drugs or those who administer CSPs. The revisions to USP 797 reflect new science and evidence based on updated guidance documents, best practices, and new learnings. 

Continue Reading →